Navigation Links
Viral hitchhiker inhibits Wolbachia bacteria's ability to proliferate

Scientists studying the widespread symbiotic bacteria Wolbachia have long been interested in its ability to proliferate. One way it does this is by hijacking sperm of its insect hosts and genetically tricking them to bear more infected females, the only sex that transmits the bacteria. Now, a new study from the MBL (Marine Biological Laboratory), published in the May 18 issue of PLoS Pathogens, demonstrates that a virus common to Wolbachia cells may be a key inhibitor of the cellular process that allows Wolbachia to manipulate insect reproduction.

Because Wolbachia are found in about 75 percent of the world's insects, the discovery could impact the development of virally delivered biocontrol tools for insects that transmit pathogens to humans or harm agriculture. It might also enable the design of alternative therapies for debilitating illnesses such as river blindness and elephantiasis, whose pathologies are caused by Wolbachia bacteria living in the parasitic worms associated with these diseases.

The new research, led by Seth Bordenstein, an Assistant Scientist in the MBL's Program in Global Infectious Diseases, shows that a virus known as WO-B interferes with Wolbachia's ability to cause cytoplasmic incompatibility, the reproductive manipulation of its insect host.

Until now, scientists believed the virus was somehow inducing this process. But viruses pirate cells to reproduce, often killing the cells as a result. So Bordenstein and his colleagues hypothesized that by preying on Wolbachia cells, the WO-B virus might reduce the incidence of cytoplasmic incompatibility in a host, not promote it.

Using DNA analysis and electron microscopy, the scientists quantified the number of WO-B viruses and Wolbachia cells in the testes of a common host: the fruit-fly-sized jewel wasp, Nasonia vitripennis. The researchers found that the virus was indeed associated with reduced bacterial growth. Then they bred the wasps and confirmed fe wer incidences of cytoplasmic incompatibility in relation to the reduced presence of the bacteria and increased presence of the virus.

"We're excited about these findings because there is a great deal of interest in deciphering the genetic and cytological mechanisms of cytoplasmic incompatibility," says Bordenstein. "We know very little about the virus, but understanding and using it may pave the way for future strategies to control insect-borne diseases."


'"/>

Source:Marine Biological Laboratory


Related biology news :

1. Viral DNA sequence a possible trigger for breast cancer
2. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
3. Viral protein influences key cell-signaling pathway
4. Viral protein helps infected T cells stick to uninfected cells
5. Viral fitness explains different resistance patterns to aids drugs
6. Viral genetic differences are possible key to HIV dementia
7. Viral marker of human migration suspect
8. Viral protein is an effective preventative against infection
9. A virus-like hitchhiker may trigger bacterial meningitis
10. Novel antiviral technology inhibits RSV infection in mice
11. Researchers find molecule that inhibits regrowth of spinal nerve cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):
(Date:8/11/2017)... ... ... Algenist continues to disrupt the skincare industry with today’s debut of GENIUS Liquid ... the key structural element skin needs to maintain its youthful appearance and Algenist is ... First to market with proprietary collagen water active , Active ...
(Date:8/10/2017)... ... August 09, 2017 , ... The ... the clinic is here. The team at Capricor Therapeutics, Inc. utilized a cardiosphere-derived ... clinical studies. , Dr. Travis Antes, head of analytical development at Capricor ...
(Date:8/10/2017)... UK (PRWEB) , ... August 10, 2017 , ... ... a new educational webinar to demonstrate how Good Clinical Practice (GCP) can ... site documents. In addition the webinar will discuss the importance of GCP compliance, how ...
(Date:8/10/2017)... Aug. 10, 2017   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade cell and tissue ... media ("BioLife" or the "Company"), today reported operational highlights ... ended June 30, 2017. Revenue from biopreservation ... million in the second quarter of 2017, an increase ...
Breaking Biology Technology: